// you're reading...

News

IC2 cloning funded by Juvenile Diabetes Research Foundation

A grant from JDRF now unable DNA cloning of IC2. The project runs for two years and was initatied in September 2008.

Welcome to ImmunoSigns

ImmunoSigns is a Biotech company founded in 1996. We offer you help in project management and R&D activities within biotechnology and immunodetection.

The core competance of ImmunoSigns is development and production of polyclonal and monoclonal antibodies and design and production of novel immunoassays and diagnostic kits, especially within the clinical area of diabetes and obesity.

Shopping Cart